Related Experiment Videos
Vaccination against cytomegalovirus
1University of Pennsylvania Wistar Institute, Doylestown, USA.
Archives of Virology. Supplementum
|May 8, 2001
Summary
Human cytomegalovirus (HCMV) causes serious disease, especially in newborns. Experimental vaccines targeting HCMV are currently under development to prevent infection and its severe consequences.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Human cytomegalovirus (HCMV) is a significant human pathogen.
- Like varicella zoster virus (VZV), HCMV can cause disease during primary and recurrent infections.
- Primary HCMV infections pose a serious risk, particularly to pregnant women and their offspring, potentially leading to mental retardation and deafness.
Purpose of the Study:
- To review the current landscape of experimental vaccines for human cytomegalovirus (HCMV).
- To highlight the importance of developing effective HCMV vaccines due to the severe health implications of the virus.
Main Methods:
- Review of existing literature on HCMV vaccine development.
- Categorization of various experimental vaccine platforms.
Main Results:
- Multiple vaccine strategies are under investigation for HCMV.
- These include live attenuated HCMV, subunit envelope glycoprotein vaccines, poxvirus vectors with inserted CMV genes, and plasmid DNA vaccines.
Conclusions:
- The development of HCMV vaccines is crucial for public health.
- A range of innovative vaccine approaches are being explored to combat HCMV infections and their sequelae.